Global Point-of-Care Diagnostics Kit Market Research Report 2022

Point-of-care testing (POCT), or bedside testing is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care. This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care and then waiting hours or days to learn the results, during which time care must continue without the desired information.
Due to the COVID-19 pandemic, the global Point-of-Care Diagnostics Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Point-of-Care Diagnostics Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Point-of-Care Diagnostics Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Blood Glucose Testing accounting for % of the Point-of-Care Diagnostics Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinics segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Point-of-Care Diagnostics Kit include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Fujifilm, BD, Sinocare, Wondfo and Yuwell, etc. In terms of revenue, the global 3 largest players have a % market share of Point-of-Care Diagnostics Kit in 2021.
This report focuses on Point-of-Care Diagnostics Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Point-of-Care Diagnostics Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Point-of-Care Diagnostics Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Fujifilm
BD
Sinocare
Wondfo
Yuwell
Runbio
KHB
WuhanEasyDiagnosis Biomedicine
DAAN GENE
ACON
J.H.Bio-Tech
UPPER Bio-Tech

Frequently Asked Questions